Skip to main content

Table 4 Comparison between the two AML subgroups (responders and non-responders) according to their pretreatment METTL3 gene expression level

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

METTL3 gene expression (pretreatment) Responders
AML cases with low normalized METTL3 gene expression (n = 15)
Non-responders
AML cases with high normalized METTL3 gene expression (n = 25)
Test p value
Median (IQR) 2.28 (1.87–2.58) 9.58 (7.7–14.6) z = 28.566 < 0.001**
  1. IQR interquartile range, z Mann–Whitney test, HS highly significant
  2. **p value < 0.001